Rad Predictors for WON

NCT ID: NCT03801070

Last Updated: 2019-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

104 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-14

Study Completion Date

2017-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective chart review study examining 1) demographic data such as age, sex, etiology of pancreatitis 2) clinical data including radiological characteristics of walled off pancreatic necrosis, walled off necrosis related admissions and readmission following endoscopic drainage, surgical or percutaneous procedures performed for the management of walled off pancreatic necrosis, and clinical outcomes following treatment of WON (including hospital readmissions, WON resolution, procedure complications, WON related death) 3) endoscopy data including indication for initial endoscopic drainage and subsequent endoscopic procedures performed for management of walled off necrosis (including additional EGD's, endoscopic drainage procedures, and/or necrosectomy)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Walled Off Pancreatic Necrosis (WON)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Less than median number necrosectomies

Group one includes patients who underwent less than median number necrosectomies

endoscopic drainage of walled off pancreatic necrosis

Intervention Type PROCEDURE

transmural drainage and mechanical debridement of solid debris (necrosectomy)

At least the median number of necrosectomies

Group two includes patients who underwent at least the median number of necrosectomies

endoscopic drainage of walled off pancreatic necrosis

Intervention Type PROCEDURE

transmural drainage and mechanical debridement of solid debris (necrosectomy)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

endoscopic drainage of walled off pancreatic necrosis

transmural drainage and mechanical debridement of solid debris (necrosectomy)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years of age who underwent endoscopic drainage of walled off pancreatic necrosis
* Patients who did not require further intervention (either surgical, percutaneous, or endoscopic) following endoscopic drainage
* Patients who required further intervention for walled off pancreatic necrosis (either surgical, percutaneous, or endoscopic) following endoscopic drainage.
* Patients who underwent percutaneous or surgical interventions prior to endoscopic drainage

Exclusion Criteria

* Pancreatic pseudocysts without any solid debris
* Under 18 years of age at the time of endoscopic drainage
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oklahoma Medical Center

UNKNOWN

Sponsor Role collaborator

Northwestern University Chicago Illinois

UNKNOWN

Sponsor Role collaborator

St. Luke's Hospital, Kansas City, Missouri

OTHER

Sponsor Role collaborator

Washington University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Washington University School of Medicine in St Louis

St Louis, Missouri, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201707053

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pancreas Cancer Surveillance Using an Abbreviated MRI
NCT04592393 ACTIVE_NOT_RECRUITING NA